HealthPartners to join Oxford University's COVID-19 vaccine trial

The Minnesota health system will enroll 1,500 people in the trial.
Publish date:

HealthPartners has announced that it has been chosen as one of the global partners in Oxford University's trial of a potential COVID-19 vaccine.

The Minnesota-based health system says it will enroll 1,500 people in a clinical trial to determine if the Oxford University vaccine, which has been developed along with pharma giant AstraZeneca, is effective at preventing the virus.

It's the only Minnesota company chosen for the trial, which is being conducted across 100 sites in the U.S., Peru, and Chile.

"HealthPartners is pleased to collaborate with AstraZeneca and Oxford University on this COVID-19 vaccine clinical trial," said Andrea Walsh, HealthPartners president and CEO.

"This research compliments our other efforts to advance COVID-19 testing, treatment and care and is an important part of our mission to improve health and well-being."

The Oxford vaccine is one of three that have entered the final stage of trials in the U.S., as countries and researchers around the world seek to bring a vaccine quickly to market.

Study participants have to be at least 18 years old, with researchers particularly interested in those with an increased risk of contracting the virus, such as health care workers, first-responders, and food service workers.

Those who work in other close contact professions, such as grocery workers and meat-packers, are also wanted to enroll.

They will also look to recruit those with underlying – but stable – conditions that make them more susceptible to severe forms of COVID-19 – such as diabetes, high blood pressure, and heart conditions.

There will also be an emphasis on enrolling people of color, with the Black, Native, and Latino communities having seen higher rates of the virus and "poorer outcomes."

Follow Bring Me The News on YouTube

"In order to test whether this vaccine is effective, we need to make sure we’re connecting with people who have the greatest likelihood of becoming ill,” said Charlene McEvoy, MD, HealthPartners pulmonologist.

"Then, over time, we’ll look at the data to see whether the vaccine was successful in preventing illness. Our hope is that we find those who received the vaccine have significantly lower rates of infection."

Two-thirds of enrollees will get the vaccine, the other third will get a placebo. These will be administered in two doses a month apart, with side effects including fever, fatigue and pain at the site of the vaccine, though data from earlier trials suggest it's "well tolerated."

For information on enrolling, look here.

Weather update for Sept. 2

Next Up


West-central MN cops warn kids to stay off ice, or 'Santa won't come'

This comes amid repeated ice warnings across the state.

covid-19, coronavirus, PPE

Nov. 29 COVID-19 update: 57 deaths, nearly 9,000 more cases

Nearly 100,000 tests were included in Sunday's report.

jim ramstad

Watch former Rep. Jim Ramstad's memorial service online

The ceremony will be live-streamed for the public on Sunday.


How high can Rashod Bateman go in the 2021 NFL Draft?

The Gophers star receiver has plenty of praise heading into next April.

TCF Bank Stadium

15 more from Gopher football team test positive for COVID-19

That brings the total number of cases from this outbreak to 40.

Teddy Bridgewater

5 questions for Vikings-Panthers Week 12 NFC battle

The Vikings welcome Teddy Bridgewater back to U.S. Bank Stadium on Sunday.

police lights

Shelter-in-place in Albert Lea after police officer shot in the chest

The officer was able to drive to an emergency room.


St. Paul officer shoots man who got out of dumpster, ran towards police

A report says the man was naked and had a steak knife.

Screen Shot 2020-11-28 at 6.58.11 PM

Gophers dominate second half to defeat Loyola-Marymount

Marcus Carr scored 26 to send the Gophers to 2-0.

Ambulance hospital emergency

Kandiyohi Co. man airlifted after hand caught in corn picker

Corn pickers are a common cause of farm accidents.

White tail deer

DNR: Passenger shot at deer out of driver's side window

The DNR said 'all sense of safety was disregarded.'


coronavirus, covid-19

U of M becomes among first to trial new COVID-19 treatment

They're treating a patient with lung failure using a new FDA-approved technique.

coronavirus, covid-19

Here is Minnesota's COVID-19 update for Saturday, June 27

The latest update from the Minnesota Department of Health.


Phase III COVID-19 vaccine trial halted after 'potentially unexplained illness'

Dr. Michael Osterholm said he'd be surprised if the illness was caused by the potential vaccine.

coronavirus, covid-19

Pfizer, BioNTech SE announce their COVID-19 vaccine is 90% effective

The companies are applying for FDA approval later in November.


HealthPartners to furlough 2,600 staff, executives taking pay cuts

It comes as hospital systems seek to limit the spread of the coronavirus.

coronavirus, COVID-19

Here is Minnesota's COVID-19 update for Saturday, July 11

The latest figures from the Minnesota Department of Health.

coronavirus, doctor, nurse, covid-19

Here is Minnesota's COVID-19 update for Saturday, Oct. 17

The latest data from the Minnesota Department of Health.